Virtu Financial’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78K | Buy |
+38,482
| New | +$78K | ﹤0.01% | 1067 |
|
|
2023
Q3 | – | Sell |
-3,992
| Closed | -$21K | – | 1573 |
|
|
2023
Q2 | $21K | Buy |
+3,992
| New | +$21K | ﹤0.01% | 1251 |
|
|
2023
Q1 | – | Sell |
-4,984
| Closed | -$93K | – | 1773 |
|
|
2022
Q4 | $93K | Sell |
4,984
-5,918
| -54% | -$110K | 0.01% | 980 |
|
|
2022
Q3 | $226K | Buy |
10,902
+3,777
| +53% | +$78.3K | 0.02% | 802 |
|
|
2022
Q2 | $148K | Buy |
+7,125
| New | +$148K | 0.01% | 850 |
|
|
2021
Q4 | – | Sell |
-2,528
| Closed | -$217K | – | 1929 |
|
|
2021
Q3 | $217K | Buy |
+2,528
| New | +$217K | 0.02% | 881 |
|
|
2021
Q2 | – | Sell |
-959
| Closed | -$107K | – | 1767 |
|
|
2021
Q1 | $107K | Sell |
959
-6,042
| -86% | -$674K | 0.01% | 1300 |
|
|
2020
Q4 | $744K | Buy |
7,001
+1,360
| +24% | +$145K | 0.08% | 314 |
|
|
2020
Q3 | $785K | Buy |
+5,641
| New | +$785K | 0.13% | 170 |
|
|
2019
Q4 | $88K | Buy |
2,212
+948
| +75% | +$37.7K | 0.01% | 1106 |
|
|
2019
Q3 | $31K | Sell |
1,264
-724
| -36% | -$17.8K | ﹤0.01% | 1249 |
|
|
2019
Q2 | $70K | Buy |
+1,988
| New | +$70K | ﹤0.01% | 1172 |
|
|
2019
Q1 | – | Sell |
-2,610
| Closed | -$125K | – | 1607 |
|
|
2018
Q4 | $125K | Buy |
+2,610
| New | +$125K | 0.01% | 1065 |
|
|
2018
Q2 | – | Sell |
-3,469
| Closed | -$196K | – | 2227 |
|
|
2018
Q1 | $196K | Buy |
3,469
+1,303
| +60% | +$73.6K | 0.01% | 1369 |
|
|
2017
Q4 | $107K | Sell |
2,166
-1,818
| -46% | -$89.8K | 0.01% | 1896 |
|
|
2017
Q3 | $303K | Buy |
+3,984
| New | +$303K | 0.02% | 1373 |
|